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ABSTRACT Crystallographic studies of insulin–protamine complexes, such as neutral protamine Hagedorn (NPH) insulin,
have been hampered by high crystal solvent content, small crystal dimensions, and extensive disorder in the protamine
molecules. We report herein in situ tapping mode atomic force microscopy (TMAFM) studies of crystalline neutral protamine
LysB28ProB29 (NPL), a complex of LysB28ProB29 insulin, in which the C-terminal prolyl and lysyl residues of human insulin are
inverted, and protamine that is used as an intermediate time-action therapy for treating insulin-dependent diabetes. Tapping
mode AFM performed at 6°C on bipyramidally tipped tetragonal rod-shaped NPL crystals revealed large micron-sized islands
separated by 44-Å tall steps. Lattice images obtained by in situ TMAFM phase and height imaging on these islands were
consistent with the arrangement of individual insulin–protamine complexes on the P41212 (110) crystal plane of NPH, based
on a low-resolution x-ray diffraction structure of NPH, arguing that the NPH and NPL insulins are isostructural. Superposition
of the height and phase images indicated that tip-sample adhesion was larger in the interstices between NPL complexes in
the (110) crystal plane than over the individual complexes. These results demonstrate the utility of low-temperature TMAFM
height and phase imaging for the structural characterization of biomolecular complexes.
INTRODUCTION
The treatment of diabetes often requires regular injections
of insulin, a 51-amino-acid dual chain polypeptide hormone
secreted by the pancreas (Banting and Best, 1922; Brange,
1987). Stored as a Zn2-hexamer in the pancreas, insulin
binds as a monomer with its transmembrane receptor. To
mimic normal physiologic insulin levels, numerous thera-
peutic insulin formulations have been devised, including
rapid-acting monomeric insulin analogues and extended
time-action therapies based on crystalline insulin forms.
Intermediate-acting therapies typically are administered as
mixtures of crystalline and amorphous forms of insulin or
cocrystalline insulin complexes prepared with protamine
(Krayenbuhl and Rosenberg, 1946). A highly basic
polypeptide composed of primarily arginine residues, pro-
tamine is isolated from fish sperm and most often used
clinically in cardiovascular surgery because it can neutralize
the effect of heparin (Weiler et al., 1985).
Known as neutral protamine Hagedorn (NPH) (Hagedorn
et al., 1936), these cocrystalline complexes can be prepared
identically from wild-type human, beef, or pork insulins
because all these insulin forms possess similar self-associ-
ation properties and readily form hexamers in the presence
of zinc (Goldman and Carpenter, 1974; Pekar and Frank,
1972). Unfortunately, crystallographic studies have pro-
vided only a low-resolution structure for a wild-type pork
insulin complex with clupeine Z, a highly purified form of
protamine (Balschmidt et al., 1991; Baker and Dodson,
1970; Simkin et al., 1969; Fullerton and Low, 1970).
A key step in insulin binding and receptor activation is
insulin multimer dissociation to the bioactive monomer
(Hollenberg, 1990; Smith et al., 1984; Brange, 1991). Con-
sequently, recent efforts to devise more effective insulin-
based therapies have focused on manipulating insulin’s
self-association (or dissociation) properties (Brange et al.,
1991). The insulin analogue, LysB28ProB29, which bears a
single site sequence inversion at positions 28 and 29 in the
human insulin B-chain, is illustrative of efforts in this regard
(Brems et al., 1992; Long et al., 1992; DiMarchi et al.,
1992). With a 300-fold reduction in the monomer–dimer
association constant relative to human insulin, LysB28ProB29
is an excellent candidate as a rapid-acting diabetes therapy.
Despite the tendency for LysB28ProB29 to exist in a mono-
meric form, it can be crystallized in the presence of phenolic
ligands and zinc as a hexameric zinc complex resembling
wild-type insulins (Ciszak et al., 1995; Bakaysa et al., 1996;
Birnbaum et al., 1997). This close structural correspondence
resulted in the development of a LysB28ProB29-based analog
of NPH insulin known as neutral protamine LysB28ProB29
(NPL), which was recently shown to be an effective inter-
mediate time-action diabetes therapy (DeFelippis et al.,
1998).
The physical properties of crystalline materials can be
influenced by various factors including crystal polymor-
phism, morphology, and size. In the case of therapeutic
complexes, the convenient direct characterization of the
local crystal–solution interface can provide key insights into
the relationship(s) between molecular orientation, surface
morphology, interfacial structure, and efficacy. Because
NPL insulins are administered as microcrystalline suspen-
sions for the treatment of diabetes, atomic force microscopy
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(AFM) studies of the crystal interface can provide insights
into the factors specific to NPL crystal dissolution and
bioavailability. We and others have demonstrated the suit-
ability of AFM for studying interfacial structure, including
direct real-space resolution of crystal lattice periodicities
and in situ confirmation of space group symmetries for
molecular crystals (Hillier and Ward, 1994; Carter et al.,
1994), and crystals of insulin (Yip and Ward, 1996; Yip et
al., 1998a,b) and other proteins (Durbin and Carlson, 1992;
Malkin et al., 1995, 1996; McPherson et al., 1996; Durbin et
al., 1993; Konnert et al., 1994; Land et al., 1995, 1996;
Walz et al., 1996; Li et al., 1999a,b).
We describe herein the results of an in situ tapping mode
AFM (TMAFM) study of NPL crystals performed in crys-
tallization liquor. Imaging performed during crystallization
over extended periods of time revealed that NPL growth
proceeded by the nucleation of two-dimensional (2D) is-
lands and their subsequent expansion. In situ AFM imaging
of the prominent exposed faces of NPL crystals revealed
lattice parameters identical to those expected for the (110)
face of NPH crystals, indicating that NPL and NPH crystals
are isostructural. (Balschmidt et al., 1991). These results
also demonstrate that TMAFM phase imaging, which was
used to acquire the in situ images of the NPL crystals, can
identify temperature-dependent protein crystallization
mechanisms, and enable assignment of plausible crystallo-
graphic structures for protein complexes.
MATERIALS AND METHODS
Following the procedure described by Balschmidt et al., crystals of NPL
were prepared from urea-containing crystallization liquors at urea concen-
trations ranging from 1 M to 4 M (Balschmidt et al., 1991). The procedure
for the 4 M urea crystallization is as follows. To a 100-ml Erlenmeyer flask
containing 194.55 mg of LysB28ProB29 (Eli Lilly and Company, Indianap-
olis, IN) and 0.569 mg ZnO, was added 25 ml of 4 M urea, 27 mM
phosphoric acid, 21 mM m-cresol, and 120 mM NaCl buffer. After gentle
swirling to dissolve the LysB28ProB29, the solution pH was adjusted to 7.3
with dilute sodium hydroxide solution. In a similar manner, 18 mg of
protamine sulfate (Yuki Gosei, Tokyo, Japan) was dissolved in 25 ml of the
same urea buffer solution (4 M urea, 27 mM phosphoric acid, 21 mM
m-cresol, and 120 mM NaCl) to yield a clear solution. The pH of the
protamine solution was adjusted to 7.3 with dilute sodium hydroxide
solution. After thermal equilibration at room temperature, 2 ml of the
LysB28ProB29 solution was added to a 25-ml glass scintillation vial. An
equal volume of the protamine solution was added to yield a clear solution.
Well-formed millimeter-sized bipyramidally tipped tetragonal rod crystals
grew from clear solution over the course of several days at ambient 23°C
temperatures. Crystallizations performed at 6°C yielded smaller, frag-
mented, stellate clusters of crystals.
All solution tapping atomic force microscopy images were acquired
using a combination contact/tapping mode liquid cell fitted to a Nanoscope
IIIA MultiMode scanning probe microscope (Digital Instruments, Santa
Barbara, CA). All images were acquired using 120 m oxide-sharpened
silicon nitride V-shaped cantilevers (Type DNP-S, Digital Instruments).
Before use, the AFM tips were exposed to ultraviolet irradiation to remove
adventitious organic contaminants from the tip surface. The AFM images
were acquired using the E scanning head, which has a maximum lateral
scan area of 14.6 [mult] 14.6 m. In situ imaging was performed on
crystals that had been transferred via pipette from the crystallization vial
into a small circular cell defined by an O-ring placed on a magnetic AFM
mount. The AFM mount was previously coated with a thin layer of vacuum
grease to affix the crystal and prevent its movement during scanning. The
AFM liquid cell was then placed carefully over the O-ring and the AFM tip
positioned using an in-line optical microscope that permitted simultaneous
viewing of the AFM tip and the crystal surface of interest. Once seated on
the O-ring, the liquid cell has restricted lateral translation, which makes it
important to minimize the need for tip positioning. We have found the
following procedure to be effective in reliably locating and positioning the
AFM tip. The cantilever is inserted into the AFM liquid cell and the laser
spot aligned on the cantilever tip. The liquid cell then is removed from the
AFM optical head and replaced with the AFM magnetic mount containing
the crystals of interest. Without adjusting the laser spot positioning screws
and while monitoring the position of the laser spot through an optical
microscope, the AFM optical head is translated in the X–Y plane until the
laser spot is located above a crystal of interest. The liquid cell containing
the premounted cantilever tip is then reseated over the O-ring. Optimal
tapping mode imaging was achieved at a cantilever drive frequency of
8.9 kHz. The cantilever drive and setpoint voltages were found to play a
significant role in determining image quality and sample integrity because
slight deviations from the optimal feedback conditions led to diminished
resolution and sample etching.
Low temperature AFM imaging was accomplished by placing the entire
AFM base inside a thermoelectric refrigeration unit (Igloo—36 qt). This
approach alleviated the mechanical and electronic interference associated
with conventional compressor-driven refrigeration. For these experiments,
the laser spot was aligned on the cantilever tip and an initial AFM image
acquired to ensure proper tip–sample engagement. The AFM tip was then
withdrawn from the sample surface a distance of 5 m and the entire unit
placed in the refrigeration unit. The entire system was allowed to reach
thermal equilibrium before reinitiating AFM imaging. The temperature in
the refrigeration unit was recorded with an Omega HH82 digital thermom-
eter fitted with a K-type thermocouple. Vertical and lateral calibration of
the piezoelectric scanner at the two operating temperatures was accom-
plished by acquiring real-space 2D lattice periodicities on the exposed
basal planes of freshly cleaved mica and graphite.
RESULTS AND DISCUSSION
The crystallization of LysB28ProB29 with protamine from
urea-containing crystallization buffers yielded well-defined
crystals with morphologies and dimensions that were de-
pendent on the concentration of the urea in the crystalliza-
tion liquor and the crystallization temperature. The
LysB28ProB29—protamine cocrystals grew at room temper-
ature from clear 4-M urea solutions as large millimeter-size
bipyramidally tipped tetragonal rods similar in appearance
to crystals reported for the porcine insulin-clupeine Z com-
plex, (Balschmidt et al., 1991) (Fig. 1). At urea concentra-
tions 4 M, mixing of the LysB28ProB29 and protamine
solutions led to the immediate formation of a white precip-
itate. Both tetragonal rod and hexagonal plate crystals were
formed from 3-M urea solutions, whereas a mixture of
single and stellate tetragonal rod crystals formed in 1-M
urea solutions. When NPL crystallization occurs from urea-
free phosphate buffer solution,1.5 [mult] 5 m tetragonal
rod crystals form within 24 hrs at 15°C (DeFelippis et al.,
1998). In all cases, crystallizations performed at 6°C re-
sulted in crystals that were smaller and more fragmented
than those obtained from ambient temperature crystalliza-
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tion. These differences in crystal morphology and size sug-
gest variations in the growth rates of various crystal planes,
reflecting modifications in the free energy of attachment of
the prenucleation crystal aggregates to the actively growing
crystal planes.
The formation of a white precipitate upon mixing of
LysB28ProB29 and protamine solutions suggests the rapid
formation of crystal nuclei. The extent of precipitation de-
creased with increasing urea content in the crystallization
liquor, and the crystals were larger and better defined,
suggesting that urea inhibits the initial stage of
LysB28ProB29–protamine association and/or the aggregation
of these complexes into crystal nuclei. This is further sup-
ported by the formation of a precipitate when NPL crystal-
lization is performed in phosphate buffer in the absence of
urea, regardless of the phosphate ion concentration. Al-
though urea is often viewed as a protein denaturant, the
levels of urea used here are unlikely to induce denaturation
of insulin. Numerous studies of insulin have demonstrated
its robustness to urea and other protein denaturants (Bryant
et al., 1992; Brems et al., 1990). Moreover, examination of
the porcine insulin-clupeine Z NPH x-ray structure and
preliminary diffraction data acquired on NPL crystals pre-
pared here did not reveal any significant conformational
distortion of the constituent insulin or LysB28ProB29 hexam-
ers (G. D. Smith, personal communication).
AFM imaging
Tapping mode AFM imaging performed in crystallization
liquor at ambient temperature on the large prolate hexagonal
faces (Fig. 1 A, Region 1) of the tetragonal NPL crystals
grown from 4-M urea solutions revealed large micron-sized
molecularly flat terraces separated by 44  6 Å steps.
However, attempts to acquire molecular scale contrast by
imaging over small areas or for extended times over large
areas were thwarted by surface etching, despite efforts to
minimize contact forces. Inspection of the crystal surface by
optical microscopy performed simultaneously with AFM
imaging revealed the gradual dissolution of the NPL crystal
outside of the region scanned by the AFM tip. We note that
the temperature of the fluid within the AFM liquid cell,
measured with an in-line thermocouple, was 33°C, about
10°C higher than the surrounding room. We surmise that
this slight elevation in temperature increases the solubility
of the NPL crystal, and ultimately initiates crystal dissolu-
tion. Remarkably, this effect was not observed in our earlier
studies of insulin and insulin analog crystallization (Yip and
Ward, 1996; Yip et al., 1998a,b). Consequently, we per-
formed in situ AFM imaging at 6°C, a condition at which
crystal dissolution and surface etching was not observed on
our experimental time scales. Recently, AFM imaging at
low temperatures has been used successfully to study bio-
logical materials (Zhang et al., 1996; Ng et al., 1997).
Our low temperature experiments were performed by
placing the AFM head inside an insulated chamber outfitted
with a simple Peltier-type thermoelectric chiller. By mini-
mizing the mechanical and electronic interference that pre-
vented the use of conventional refrigerators, this approach
enabled stable imaging at reduced temperatures. Tapping
mode AFM imaging performed in crystallization liquor at
6°C on the prominent prolate hexagonal faces of the bipy-
ramidally tipped tetragonal rod NPL crystals revealed large
well-ordered crystal terraces separated by 44  4-Å steps.
The step heights measured at 33°C and 6°C differed by
1.0 Å, confirming that the calibration of the piezoelectric
scanner was not significantly affected by the reduction in
operating temperature.
Molecular level contrast obtained by height and phase
imaging on the exposed crystal faces of NPL revealed an
ordered lattice with real-space parameters of a1  76.0 Å;
a2  118 Å; a3  75.2 Å; 12  46.5°; 23  41.3° (Fig.
2). These values argue that the crystal possesses p4mm
plane group symmetry, an observation consistent with pre-
FIGURE 1 Optical micrographs of LysB28ProB29–protamine single crys-
tals grown at (A) room temperature and (B) 6°C. Magnification: 200[mult].
In both sets of micrographs, the tetragonal rod morphology is apparent. (A)
The region marked 1 indicates a typical prolate hexagonal crystal face
imaged during the AFM studies. (B) Rapid crystal nucleation and growth
at the lower crystallization temperature is reflected in fragmented and
stellate appearance of the crystals.
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liminary x-ray diffraction studies suggested that these crys-
tals belong to the 4/mmm Laue space group (G. D. Smith,
personal communication). Comparison with the porcine in-
sulin–clupeine Z NPH complex, which belongs to the
P41212 space group (or its enantiomeric complement
P43212) with lattice parameters a  b  62.9 Å, c  85.9
Å,       90°, revealed a fair correspondence
between the a1 and a3 vectors determined by AFM and the
symmetry equivalent 111 (88.9 Å) and [001] (85.9 Å)
lattice parameters, respectively, for the P41212 (110) crystal
FIGURE 2 Tapping mode AFM images acquired in solution at 6°C on the prolate hexagonal face of a LysB28ProB29–protamine single crystal. Unfiltered
(A) height and (B) phase-encoded AFM images of a large molecularly flat terrace revealing well-ordered surface periodicities. Note correspondence between
height and phase image periodicities. Scan rate: 2.0 Hz. Image size: 250 nm. The AFM unit cells deduced by Fourier analysis are shown as solid white
lines. (C) Two-dimensional Fourier power spectrum of phase image (B) revealing fourfold symmetry corresponding to real-space vectors a1 76.0 Å; a2
118 Å; a3  75.2 Å; 12  46.5°; 23  41.3°. (D) Molecular model of the (110) crystal plane of the porcine insulin–clupeine Z complex. The model was
prepared using Cerius2 version 2.1 (Molecular Simulations Inc. San Diego CA) from coordinates registered with the Brookhaven Protein Data Bank as entry
code: pdb7ins.ent.
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plane (Balschmidt et al., 1991). The experimentally deter-
mined a2 vector, therefore, is assigned to the symmetry
equivalent 111 (124 Å) lattice parameters of the NPH
crystals. The small discrepancy between the AFM data for
NPL and the crystallographic analysis for NPH may be due
to slight reconstruction of the NPL crystal surface. Never-
theless the observed 44 Å vertical spacing between individ-
ual NPL crystal terraces is comparable to the interplanar
spacing of NPH (110) planes corroborating that the NPH
and NPL crystal forms are isostructural.
Phase contrast imaging
During tapping mode imaging, the AFM tip is oscillated at
a user-specified frequency and drive amplitude such that the
tip only contacts the sample surface intermittantly. The
optimal choice of frequency and amplitude depends on the
nature of the surrounding fluid, the dynamic response of the
sample surface, and the mechanical coupling of the AFM
liquid cell with the fluid. The AFM control loop monitors
the amplitude dampening of the tip oscillation as the tip
contacts the sample surface and adjusts the relative sample-
tip separation accordingly. This feedback mechanism thus
provides image contrast associated with constant amplitude
damping by the surface. Recent reports have demonstrated
that the phase shift between the applied and detected tip
oscillation can provide information regarding intrinsic local
surface modulus and viscoelasticity (Winkler et al., 1996;
Maganov et al., 1997). Under constant amplitude imaging
conditions, the applied tip force depends strongly on sample
and tip stiffness, drive frequency, and sample deformation
(Spatz et al., 1995). Whereas, in air, the amplitude of the tip
oscillations can be several tens of nanometers with corre-
sponding high applied transient contact forces, tapping
mode imaging performed in solution involves small tip
oscillations and low setpoint amplitudes, typically 5 nm.
Under these light tapping conditions, the observed phase
shift presumably reflects differences in the amount of en-
ergy dissipated during tip contact with the surface (Cleve-
land et al. 1998). Such energy losses can arise through
convolution of the mechanical properties of the surface with
electrostatic forces between the tip and surface. Indeed, the
extent of mechanical deformation of the individual protein
domains will depend on the magnitude of the applied tip
force and the viscoelastic characteristics of the protein, as
reported in contact mode AFM studies of 2D protein crys-
tals (Muller et al.; 1995).
Although the basis for the absolute phase image contrast
values remains unclear, significant relative phase contrast
was observed as the tip traversed over the individual
LysB28ProB29 hexamer–protamine complexes and the adja-
cent interstitial contact regions (Fig. 2 B). The excellent
registry of the absolute phase and height regions clearly
demonstrates that phase imaging can be used to acquire
nanometer-scale resolution of protein crystal surfaces. In the
present study, phase contrast imaging provided clearer res-
olution of the 2D surface lattice of the NPL crystals than the
corresponding amplitude or height images, including clear
delineation of the crystal terrace edges (Fig. 2 B).
The magnitude of the phase shift observed during
TMAFM imaging in fluids can be correlated with specific
adhesive interactions between the tip and surface, with the
phase lag increasing with increasing adhesion, and energy
dissipation (Noy et al., 1998; Brandsch et al., 1997;
FIGURE 3 In situ tapping mode images of LysB28ProB29-protamine complex acquired at (A) 33°C and (B) 6°C. Images were acquired on the same crystal
in the same region of a large prolate hexagonal crystal face. Change in surface topography supports transition from terrace expansion growth seen in (A)
to a 2D nucleation and island expansion mechanism seen in (B). Image size: 5 [mult] 5 m. Scan rate: 2.0 Hz.
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Czajkowsky et al.; 1998). In the case of crystalline protein
complexes, these interactions are expected to vary periodi-
cally, reflecting regular variations in surface topography
and changes in the local surface characteristics, including
charge, of the individual complexes. On the (110) crystal
plane, the individual insulin hexamer–protamine complexes
are oriented edge-on with the central Zn2 ion channel
oriented along the symmetry-equivalent 111 directions. In
this orientation, only certain surfaces of the complexes are
interrogated by the scanning tip. This was confirmed by
superposition of the topography and phase-contrast images
that indicated the dark regions on the phase image, corre-
sponding to increased adhesion and energy dissipation, co-
incided with the interstitial regions between hexamers on
the (110) plane. The clear phase and height difference
between individual LysB28ProB29 hexamer–protamine com-
plexes therefore suggests that the observed phase image
contrast arises from a combination of viscoelasticity and
adhesion, likely due to variations in local surface charge,
between the individual LysB28ProB29 hexamer–protamine
complexes as oriented on the (110) crystal plane.
Crystal growth
Tapping mode AFM performed in crystallization liquor at
33°C before the onset of gross crystal dissolution, revealed
gradual expansion of large (110) crystal terraces similar to
growth of (001) crystal planes observed previously for other
insulin forms. (Fig. 3 A) (Yip and Ward, 1996; Yip et al.,
1998a,b). However, in situ imaging performed at 6°C re-
vealed rapid 2D nucleation (Volmer–Weber growth) on the
large (110) crystal terraces (Fig. 3 B). In contrast to our
earlier AFM studies of LysB28ProB29, no screw dislocations
were observed on the actively growing crystal surfaces at
either imaging temperature (Yip et al., 1998a). The obser-
vation of Volmer–Weber growth at low temperature is not
unexpected because the supersaturation and rate of nucle-
ation increase with decreasing temperature. This is consis-
FIGURE 4 (A–F) Real-time in situ tapping mode AFM images collected at 0, 129, 515, 772, 1030, and 1416 s, respectively, in crystallization liquor at
33°C. The images reveal the active adsorption and desorption of 17 Å tall aggregates on the actively growing crystal terrace. Persistent aggregates, denoted
by the white arrows, confirm the lack of image drift. (A) The white outline indicates a region where a single molecular layer deep hole has formed. Note
how this region undergoes reconstruction on the time frame of 129 s, with no accompanying dislocation or crystal defect formation. The dotted white
outlines in (A–B) highlight aggregates initially present on the terrace surface that have desorbed from the terrace in (C). In (F), the white outline denotes
location of two new aggregates that deposited at the edge of the growing terraces. Image size: 1 [mult] 1 m. Scan rate: 2.0 Hz.
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tent with the qualitative observation that crystallization of
NPL at reduced temperatures affords small, highly facetted
and fragmented crystals (Fig. 1).
Sequential AFM images acquired at 6°C over extended
periods revealed active adsorption and desorption of 17-Å-
tall aggregates on the exposed (110) plane of the NPL
crystals (Fig. 4). Although the scanning motion of the AFM
tip may enhance growth by increasing convection near the
sample surface, we did not observe tip-induced nucleation
events or tip-induced direct incorporation of aggregates into
the crystal terraces. Unambiguous identification of the 17-
Å-tall aggregates is difficult because there are two distinct
molecular species, LysB28ProB29 and protamine, in the crys-
tallization liquor. The 17-Å height is incommensurate with
the 44-Å terrace heights, and somewhat smaller than the
insulin hexamer aggregates reported in our earlier studies
(Yip and Ward, 1996; Yip et al., 1998a,b). Although the
shape and dimensions of the AFM tip can contribute to an
overestimation of lateral feature size, the observed vertical
dimensions generally are immune to such effects (Mo¨ller et
al., 1999). Because NPL crystallization is performed in the
presence of phenol and zinc, it is likely that LysB28ProB29
exists in a hexameric form, although the existence of a small
population of LysB28ProB29 monomers cannot be dis-
counted. However, NPL crystallizes at pH 7.3, which is
slightly greater than the reported point of zero charge (6.0–
7.0) for NPL (DeFelippis et al., 1998). This would favor
adsorption of positively charged protamine molecules (pI
13.8, Hoffman et al., 1990) through electrostatic interac-
tions onto the negatively charged NPL crystal surface. We
note that previous isothermal calorimetry studies described
the electrostatic binding of hexameric human insulin to the
surface of NPH crystals in a similar fashion (Dodd et al.,
1995). These considerations argue that the small features
described above are likely protamine aggregates. Epitaxial
assembly of protamine on the exposed surface of the NPL
crystals is unlikely because the crystal structure of the
related NPH complex revealed that the protamine molecules
are intertwined within the individual insulin hexamers and
are not freely exposed on any crystal planes (Balschmidt et
al., 1991). This contrasts with our earlier studies that re-
vealed the epitaxial assembly of aggregates, presumably
insulin hexamers, on actively growing insulin crystal sur-
faces (Yip and Ward, 1996; Yip et al., 1998a,b).
The present studies demonstrate further that low temper-
ature TMAFM performed in solution enables the direct
assessment of the interfacial structure, morphology, and
crystal growth characteristics for crystalline protein com-
plexes. This approach enabled direct determination of mo-
lecular packing on exposed crystal planes by both conven-
tional height and phase imaging, the latter reflecting
differences in the local energy dissipation arising from the
interaction of the tapping tip with the surface of the protein
crystal. Phase imaging clearly revealed periodicities consis-
tent with the arrangement of individual LysB28ProB29 hex-
amer–protamine complexes, thus enabling direct in situ
identification of specific lattice periodicities and plane
group symmetries. These observations also illustrate that
AFM phase imaging will become increasingly useful for
high-resolution electrostatic mapping of domains within
biomolecular complexes.
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